Renaissance Technologies - KEMPHARM INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$640
-4.9%
132,700
+0.6%
0.00%0.0%
Q2 2023$673
+17.9%
131,900
+27.1%
0.00%0.0%
Q1 2023$571
+53.5%
103,800
+28.1%
0.00%0.0%
Q4 2022$372
-99.9%
81,000
+12.7%
0.00%0.0%
Q3 2022$449,000
-2.6%
71,900
-30.5%
0.00%0.0%
Q2 2022$461,000
-49.3%
103,394
-42.8%
0.00%0.0%
Q1 2022$909,000
+464.6%
180,791
+877.2%
0.00%
Q4 2021$161,000
-89.6%
18,500
-88.8%
0.00%
-100.0%
Q3 2021$1,545,000165,6000.00%
Other shareholders
KEMPHARM INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nantahala Capital Management 2,308,216$11,125,6010.95%
Retirement Planning Co of New England, Inc. 347,402$1,674,4780.93%
Mystic Asset Management, Inc. 203,283$979,8240.55%
Kovack Advisors, Inc. 124,109$598,2080.08%
Arete Wealth Advisors, LLC 80,729$389,1140.07%
City State Bank 14,224$690.04%
IFG Advisors, LLC 12,900$62,1780.02%
Measured Wealth Private Client Group, LLC 10,000$48,2000.02%
VisionPoint Advisory Group, LLC 6,860$33,0650.01%
OCCUDO QUANTITATIVE STRATEGIES LP 22,615$109,0040.01%
View complete list of KEMPHARM INC shareholders